SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Munch-a-Biotech Today
An SI Board Since December 1998
Posts SubjectMarks Bans
3158 136 0
Emcee:  Biomaven Type:  Unmoderated
Introduction Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2983Not that I am aware, only speculation on my part. That is, rampant speculation.Biotech Jim-7/2/2012
2982Has he stated that publicly?DewDiligence_on_SI-7/2/2012
2981It seems that the market thinks today that INCY may be next. After all, Paul F.Biotech Jim-7/2/2012
2980BMRN, AFFY, THRX, and RIGL are the most likely candidates for the next significaDewDiligence_on_SI-7/2/2012
2979Table of recent biotech buyouts and premiums: siliconinvestor.comDewDiligence_on_SI-7/2/2012
2978Reports: Sanofi, Merck Bid At Least $25 Per Share For Amylinmopgcw-5/25/2012
2977MELBOURNE, AUSTRALIA--(Marketwire -04/23/12)- Biota Holdings Limited (ASX: BTA.nigel bates-4/23/2012
2976LONDON (ShareCast) - Pharmaceuticals giant AstraZeneca (LSE: AZN.L - news) hasnigel bates-4/23/2012
2975Surprised no one posted the GSK bid for HGSI: Human Genome Sciences, Inc. – Thunigel bates-4/23/2012
2974OT Humor: Headline on my DowJones news feed today: "Fanatics to acquire Drtuck-4/16/2012
2973Spectrum buying Allos for $1.82 plus CVRs for EU milestones for Folotyn. Sees mtuck-4/5/2012
2972Amylin jumps 46% to $22.50 after Bloomberg reports rejection of takeover bid fidr.praveen-3/28/2012
2971 ISTA Pharm to be acquired by Bausch + Lomb for $9.10/share in cash ( ISTA) 8.Ian@SI-3/26/2012
2970WESTON & CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Biogen Idec (NASDAQ: BIIB - nigel bates-2/14/2012
2969AMGN buys MITI for $11 per share... This is really too bad, would have enjoyed spgo-neil-1/26/2012
2968THOUSAND OAKS, Calif., and ROCKVILLE, Md., Jan. 26, 2012 /PRNewswire/ -- Amgen (nigel bates-1/26/2012
2967naw, cashed out a while back. it was a great run though.mopgcw-1/25/2012
2966It's a hostile offer—not a fait accompli.DewDiligence_on_SI-1/25/2012
2965Roche Diagnostics takes out Illumina for $44.50. Dunno if you still own this. tuck-1/25/2012
2964IDIX takeout vig is somewhat silly insofar as NVS has the practical ability to bDewDiligence_on_SI-1/10/2012
2963from a long-term vrtx holder (sold after approval).............. pfffffffffffffscaram(o)uche-1/10/2012
2962BMS' takeout of Inhibitex (INHX) for $2.5 billion ($26/share) represents an tuck-1/10/2012
2961masshightech.com Wednesday, December 21, 2011 Millennium adding two cancer prscaram(o)uche-12/22/2011
2960old stuff..... Plexxikon..... couldn't find this info in the thread when I wscaram(o)uche-12/9/2011
2959The 89% premium is the highest ever in a biotech deal valued at more than $10B, DewDiligence_on_SI-11/21/2011
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News